亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

濟(jì)南金達(dá)藥化有限公司  

生產(chǎn)自銷醫(yī)藥原料藥及中間體

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:田建
  • 電話:0531-88900314
  • 郵件:sales@jindapharm.com
  • 傳真:0531-88902114
  • QQ:604080418
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
呋喃妥因
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 山東付款后3天內(nèi)
過期 長期有效
更新 2014-06-23 13:23
 
詳細(xì)信息
 A: 中國藥典(2010)。

外觀:黃色結(jié)晶性粉末
含量:98.0~102.0%
干燥失重:≤1.0%
熾灼殘?jiān)?≤0.1%
酸度:5.5~7.0
有關(guān)物質(zhì):≤ 1%
呋喃西林:≤ 0.01%
B: 符合歐洲藥典(EP6)版。
外觀:黃色結(jié)晶性粉末或黃色結(jié)晶
含量:98.0~102.0%
干燥失重:≤1.0%
禁發(fā) 硫酸灰分:≤0.1%
有關(guān)物質(zhì):≤1.0%
C: 符合美國USP32版。
外觀:檸檬黃色結(jié)晶性粉末
含量:98.0 ~ 102.0% (按干燥品計(jì)算,含 C8H6N4O5)
硝基糠醛二乙酯:≤ 1.0%
呋喃西林限量:≤ 0.01%
水分:≤ 1.0%

作用與用途:抗菌藥
批準(zhǔn)文號:國藥準(zhǔn)字H37022205

©2025 濟(jì)南金達(dá)藥化有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:3790  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |